In non-small cell lung cancer (NSCLC), IgM deposits are observed, pointing to a potential binding of the IgM to the neoantigens present at the tumor cell surface and a triggering of the classical pathway activation [34]. The gene discussed is CD40LG; the disease is non-small cell lung carcinoma.